Literature DB >> 31982236

Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials.

E A Al-Moraissi1, R Farea2, K A Qasem3, M S Al-Wadeai4, M E Al-Sabahi4, G M Al-Iryani5.   

Abstract

A network meta-analysis (NMA) of randomized controlled trials (RCTs) was performed to assess the effectiveness of various types of occlusal splint in the management of temporomandibular disorders (TMDs) and to rank them according to their effectiveness. An electronic search was undertaken to identify RCTs published until August 2019. Predictor variables were control, non-occluding splint, hard stabilization splint (HSS), soft stabilization splint (SSS), prefabricated splint, mini-anterior splint, anterior repositioning splint (ARS), and counselling therapy (CT) with or without HSS. Outcome variables were pain improvement, post-treatment pain intensity, improvement in mouth opening, and disappearance of temporomandibular joint (TMJ) sounds. Forty-eight RCTs were included. There was a significant decrease in post-treatment pain intensity in arthrogenous TMDs after ARS (low quality evidence), CT+HSS (moderate quality evidence), mini-anterior splints (very low quality evidence), and HSS alone (low quality evidence), when compared to the control. There was a significant decrease in post-treatment pain intensity in myogenous TMDs with mini-anterior splints (very low quality evidence), SSS (very low quality evidence), CT alone (moderate quality evidence), CT+HSS (moderate quality evidence), and HSS alone (moderate quality evidence), when compared to control. ARS and CT were superior in decreasing TMJ clicking than control and HSS alone. The three highest-ranked treatments for post-treatment pain reduction in arthrogenous TMDs were ARS (92%, very low quality evidence), CT+HSS (67.3%, low quality evidence), and HSS alone (52.9%, moderate quality evidence). For myogenous TMDs, they were mini-anterior splints (86.8%, low quality evidence), CT+HSS (61.2%, very low quality evidence), and HSS alone (59.7%, moderate quality evidence). Based on this NMA of 48 RCTs, there is moderate to very low quality evidence confirming the effectiveness of occlusal splint therapy in the treatment of TMDs. Multimodal therapy consisting of CT+HSS may produce the maximum improvement for TMD patients.
Copyright © 2020 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NTI-tss; TMJ clicking; anterior repositioning splint; arthrogenous temporomandibular disorders; counselling therapy; hard stabilization splint; myogenous temporomandibular disorders; network meta-analysis; non-occluding splint; occlusal splint therapy; randomized controlled clinical trials; self-management

Mesh:

Year:  2020        PMID: 31982236     DOI: 10.1016/j.ijom.2020.01.004

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  10 in total

1.  Oral splint therapy in patients with Menière's disease and temporomandibular disorder: a long-term, controlled study.

Authors:  Edoardo Bernkopf; Vincenzo Capriotti; Giulia Bernkopf; Emilia Cancellieri; Andrea D'Alessandro; Alberto Vito Marcuzzo; Caterina Gentili; Giovanni Carlo De Vincentiis; Giancarlo Tirelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-26       Impact factor: 3.236

Review 2.  An Overview of Anterior Repositioning Splint Therapy for Disc Displacement-related Temporomandibular Disorders.

Authors:  Yan-Ning Guo; Sheng-Jie Cui; Yan-Heng Zhou; Xue-Dong Wang
Journal:  Curr Med Sci       Date:  2021-06-25

3.  Personalized Biomechanical Analysis of the Mandible Teeth Behavior in the Treatment of Masticatory Muscles Parafunction.

Authors:  Denis Gribov; Mikhail Antonik; Denis Butkov; Alexandr Stepanov; Pavel Antonik; Yaser Kharakh; Anton Pivovarov; Sergey Arutyunov
Journal:  J Funct Biomater       Date:  2021-04-09

4.  Internet-Based Multimodal Pain Program With Telephone Support for Adults With Chronic Temporomandibular Disorder Pain: Randomized Controlled Pilot Trial.

Authors:  Julia Lam; Peter Svensson; Per Alstergren
Journal:  J Med Internet Res       Date:  2020-10-13       Impact factor: 5.428

5.  Are occlusal splints effective in reducing myofascial pain in patients with muscle-related temporomandibular disorders? A randomized-controlled trial.

Authors:  Andrea Deregibus; Martina Ferrillo; Maria Grazia Piancino; Maria Chiara Domini; Alessandro de Sire; Tommaso Castroflorio
Journal:  Turk J Phys Med Rehabil       Date:  2021-03-04

6.  Patients' perceptions on temporomandibular disorder treatment with hydrostatic oral splints - a pilot study.

Authors:  H Sabbagh; A Sabbagh; A Heppner; C Auer; A Wichelhaus; L Hoffmann
Journal:  BDJ Open       Date:  2022-02-05

7.  The Efficacy of Neck and Temporomandibular Joint (TMJ) Manual Therapy in Comparison With a Multimodal Approach in the Patients with TMJ Dysfunction: A Blinded Randomized Controlled Trial.

Authors:  Khaled Rezaie; Ali Amiri; Esmaeil Ebrahimi Takamjani; Gholamreza Shirani; Saman Salehi; Leila Alizadeh
Journal:  Med J Islam Repub Iran       Date:  2022-05-04

8.  A Randomized Controlled Trial Evaluating the Levels of the Biomarkers hs-CRP, IL-6, and IL-8 in Patients with Temporomandibular Disorder Treated with LLLT, Traditional Conservative Treatment, and a Combination of Both.

Authors:  Abdalwhab Ma Zwiri; Wan Muhamad Amir W Ahmad; Jawaad Ahmed Asif; Khoo Suan Phaik; Adam Husein; Nur Karyatee Kassim; Zuryati Ab-Ghani
Journal:  Int J Environ Res Public Health       Date:  2022-07-23       Impact factor: 4.614

9.  Changes in Maximum Mandibular Mobility Due to Splint Therapy in Patients with Temporomandibular Disorders.

Authors:  Bernhard Wiechens; Svea Paschereit; Tristan Hampe; Torsten Wassmann; Nikolaus Gersdorff; Ralf Bürgers
Journal:  Healthcare (Basel)       Date:  2022-06-09

Review 10.  Temporomandibular Disorders: Current Concepts and Controversies in Diagnosis and Management.

Authors:  Dion Tik Shun Li; Yiu Yan Leung
Journal:  Diagnostics (Basel)       Date:  2021-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.